Anusara Daenthanasanmak

CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response

Shilpak Chatterjee, Anusara Daenthanasanmak, Paramita Chakraborty et al. · Cell Metabolism · 2017 · 264 citations · Full text

Life Sciences, Immunology, Oncology +10

Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation

Hung Nguyen, Shilpak Chatterjee, Kelley M.K. Haarberg et al. · Journal of Clinical Investigation · 2016 · 125 citations · Full text

Life Sciences, Biochemistry, Immunology +17

Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation

Brian C. Betts, David Bastian, Supinya Iamsawat et al. · Proceedings of the National Academy of Sciences · 2018 · 75 citations

Life Sciences, Hematology, Immunology +17

Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice

Anusara Daenthanasanmak, Supinya Iamsawat, Paramita Chakraborty et al. · Blood · 2018 · 72 citations · Full text

Life Sciences, Immunology, Molecular Biology +13

Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response

Shilpak Chatterjee, Paramita Chakraborty, Anusara Daenthanasanmak et al. · Clinical Cancer Research · 2018 · 65 citations · Full text

Medicine, Oncology, Pharmacology +17